Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $14.2B | $13.12B | +8.27% |
Operating Income | $3.99B | $4.05B | -1.39% |
Net Income | $4.41B | $3.95B | +11.61% |
EPS (Basic) | $40.90 | $37.05 | +10.39% |
EPS (Diluted) | $38.34 | $34.77 | +10.27% |
R&D Expense | $5.13B | $4.44B | +15.61% |
SG&A Expense | $2.95B | $2.63B | +12.28% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $37.76B | $33.08B | +14.15% |
Current Assets | $18.66B | $19.48B | -4.20% |
Total Liabilities | $8.41B | $7.11B | +18.27% |
Current Liabilities | $3.94B | $3.42B | +15.22% |
Stockholders' Equity | $29.35B | $25.97B | +13.02% |
Cash & Equivalents | $2.49B | $2.73B | -8.86% |
Long-Term Debt | $1.98B | $1.98B | +0.08% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $4.42B | $4.59B | -3.78% |
Investing Cash Flow | $-2.47B | $-3.19B | +22.51% |
Financing Cash Flow | $-2.2B | $-1.79B | -22.93% |
Dividends Paid | $0 | $0 | — |
Share Buybacks | $2.6B | $2.23B | +16.48% |
D&A | $482.9M | $421M | +14.70% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 28.1% | 30.9% | -2.75% |
Net Margin | 31.1% | — | — |
ROE | 15.0% | — | — |
ROA | 11.7% | — | — |
Current Ratio | $4.731 | — | — |
Debt to Equity | $0.286 | — | — |
Other companies in Biotechnology